Cargando…
Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292436/ http://dx.doi.org/10.1186/2051-1426-2-S3-P214 |
| _version_ | 1782352484790960128 |
|---|---|
| author | Yopp, Adam Kallinteris, Nikoletta Huang, Xianming Shan, Joe Menander, Kerstin Hutchins, Jeff King, Steve Xu, Xiaowei Gabrilovich, Dmitry Brekken, Rolf |
| author_facet | Yopp, Adam Kallinteris, Nikoletta Huang, Xianming Shan, Joe Menander, Kerstin Hutchins, Jeff King, Steve Xu, Xiaowei Gabrilovich, Dmitry Brekken, Rolf |
| author_sort | Yopp, Adam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4292436 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42924362015-01-15 Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma Yopp, Adam Kallinteris, Nikoletta Huang, Xianming Shan, Joe Menander, Kerstin Hutchins, Jeff King, Steve Xu, Xiaowei Gabrilovich, Dmitry Brekken, Rolf J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292436/ http://dx.doi.org/10.1186/2051-1426-2-S3-P214 Text en Copyright © 2014 Yopp et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Yopp, Adam Kallinteris, Nikoletta Huang, Xianming Shan, Joe Menander, Kerstin Hutchins, Jeff King, Steve Xu, Xiaowei Gabrilovich, Dmitry Brekken, Rolf Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma |
| title | Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma |
| title_full | Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma |
| title_fullStr | Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma |
| title_full_unstemmed | Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma |
| title_short | Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma |
| title_sort | correlative studies of a phase ii clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292436/ http://dx.doi.org/10.1186/2051-1426-2-S3-P214 |
| work_keys_str_mv | AT yoppadam correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma AT kallinterisnikoletta correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma AT huangxianming correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma AT shanjoe correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma AT menanderkerstin correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma AT hutchinsjeff correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma AT kingsteve correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma AT xuxiaowei correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma AT gabrilovichdmitry correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma AT brekkenrolf correlativestudiesofaphaseiiclinicalstudyofbavituximabandsorafenibinpatientswithadvancedhepatocellularcarcinoma |